COOThe Cooper Companies
$62.37-11% 1Y
$62.37
$53.7052 weeks$84.32
The business
How COO's business earns
The Cooper Companies earns 3.8% on the capital it employs against an estimated 9.0% cost of capital.
3.8%
Return on invested capital · cost of capital 9.0% · 5.2 points below the estimated cost of capital
- Operating margin
- 13%
Operating margin · Medical Instruments & Supplies median 7.2% · 12 months to Jul 31, 2026
- Cash conversion
- 2.40×
Cash conversion · 1.67× a year ago · operating cash flow divided by operating profit after tax
- Share count, year on year
- −3.3%
Share count, year on year · fewer shares than a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 13% |
| FY2021 | 17% |
| FY2022 | 15% |
| FY2023 | 15% |
| FY2024 | 18% |
| FY2025 | 17% |
Details›
- Gross margin12 months to Jul 31, 2026
- 66%
- Operating margin12 months to Jul 31, 2026
- 13%
- Net margin12 months to Jul 31, 2026
- 13%
- Free cash flow margin
- 16%
- R&D as % of revenue
- 4.0%
- Revenue, trailing twelve months
- $4.24B
- Free cash flow, trailing twelve months
- $678M
- Net income, trailing twelve months
- $570M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 3.8%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screensFree cash flow yield of 5 to 30 percent
Medical Instruments & Supplies
The closest names by size in the same industry